Trials / Completed
CompletedNCT02716532
Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will be targeting patients suffering from acute brain injury (ABI), including those with severe trauma brain injury (sTBI) and those with aneurysmal sub arachnoid hemorrhage (aSAH). This clinical study is an open-label, non-randomized, single-center, exploratory metabolic study. The primary objective is to determine changes from baseline (before enteral administration of Peptamen AF) in plasma and brain extracellular levels of MCFAs and Ketone bodies in sTBI patients upon Peptamen AF nutritional support.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Peptamen AF | Each patient will receive Peptamen AF throughout the trial. |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-05-17
- Completion
- 2017-11-15
- First posted
- 2016-03-23
- Last updated
- 2018-01-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02716532. Inclusion in this directory is not an endorsement.